Group One Trading’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-26,667	Closed	-$426K	–	8058
2025 Q4	$205K	Buy	+26,667	New	+$210K	0.01%	4349
2025 Q2	–	Sell	-11,895	Closed	-$43.3K	–	8327
2025 Q1	$37.8K	Sell	11,895 -40,873	-77%	-$193K	﹤0.01%	5371
2024 Q4	$282K	Buy	52,768 +47,208	+849%	+$352K	0.01%	3640
2024 Q3	$29.4K	Buy	+5,560	New	+$20K	﹤0.01%	5002
2024 Q2	–	Sell	-4,604	Closed	-$8.58K	–	7094
2024 Q1	$8.2K	Sell	4,604 -32,060	-87%	-$67K	﹤0.01%	5974
2023 Q4	$64.5K	Buy	36,664 +9,565	+35%	+$14K	﹤0.01%	4851
2023 Q3	$39.6K	Buy	+27,099	New	+$57.3K	﹤0.01%	5316
2022 Q4	–	Sell	-7,049	Closed	-$6.24K	–	7591
2022 Q3	$6K	Sell	7,049 -21,748	-76%	-$20.7K	﹤0.01%	6739
2022 Q2	$29K	Buy	28,797 +19,722	+217%	+$24.2K	﹤0.01%	6001
2022 Q1	$15K	Sell	9,075 -20,322	-69%	-$37.2K	﹤0.01%	6942
2021 Q4	$71K	Buy	+29,397	New	+$114K	﹤0.01%	6035
2021 Q3	–	Sell	-7,076	Closed	-$20.9K	–	8445
2021 Q2	$19K	Sell	7,076 -2,875	-29%	-$7.92K	﹤0.01%	7211
2021 Q1	$31K	Buy	9,951 +4,551	+84%	+$16.4K	﹤0.01%	6529
2020 Q4	$19K	Buy	5,400 +5,300	+5,300%	+$21.3K	﹤0.01%	5542
2020 Q3	$0	Buy	+100	New	+$400	﹤0.01%	6308